[1] P. Safarzadeh Kozani, P. Safarzadeh Kozani, F. Rahbarizadeh, CAR-T cell therapy in T-cell malignancies: Is success a low-hanging fruit?, Stem Cell Res Ther 12(1) (2021) 527.
[2] J. Chen, I.F. Lopez-Moyado, H. Seo, C.J. Lio, L.J. Hempleman, T. Sekiya, A. Yoshimura, J.P. Scott-Browne, A. Rao, NR4A transcription factors limit CAR T cell function in solid tumours, Nature 567(7749) (2019) 530-534.
[3] Z.Z. Zhang, T. Wang, X.F. Wang, Y.Q. Zhang, S.X. Song, C.Q. Ma, Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies, Pharmacol Res 175 (2022) 106036.
[4] T. Yan, L. Zhu, J. Chen, Current advances and challenges in CAR T-Cell therapy for solid tumors: tumor-associated antigens and the tumor microenvironment, Exp Hematol Oncol 12(1) (2023) 14.
[5] Y.R. Li, Z.S. Dunn, Y. Zhou, D. Lee, L. Yang, Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies, Cells 10(12) (2021) 3497.
[6] Y. Jiang, Y. Li, B. Zhu, T-cell exhaustion in the tumor microenvironment, Cell Death Dis 6 (2015) e1792.
[7] J.S. Dolina, N. Van Braeckel-Budimir, G.D. Thomas, S. Salek-Ardakani, CD8(+) T Cell Exhaustion in Cancer, Front Immunol 12 (2021) 715234.
[8] Y.R. Li, Z.S. Dunn, Y. Yu, M. Li, P. Wang, L. Yang, Advancing cell-based cancer immunotherapy through stem cell engineering, Cell Stem Cell 30(5) (2023) 592-610.
[9] L.J. Eggermont, L.E. Paulis, J. Tel, C.G. Figdor, Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells, Trends Biotechnol 32(9) (2014) 456-65.
[10] J. Oh, X. Xia, W.K.R. Wong, S.H.D. Wong, W. Yuan, H. Wang, C.H.N. Lai, Y. Tian, Y.P. Ho, H. Zhang, Y. Zhang, G. Li, Y. Lin, L. Bian, The Effect of the Nanoparticle Shape on T Cell Activation, Small (2022) e2107373.
[11] F.S. Majedi, M.M. Hasani-Sadrabadi, T.J. Thauland, S. Li, L.-S. Bouchard, M.J. Butte, Augmentation of T-Cell Activation by Oscillatory Forces and Engineered Antigen-Presenting Cells, Nano Letters 19(10) (2019) 6945-6954.
[12] F.S. Majedi, M.M. Hasani-Sadrabadi, T.J. Thauland, S.G. Keswani, S. Li, L.S. Bouchard, M.J. Butte, Systemic enhancement of antitumour immunity by peritumourally implanted immunomodulatory macroporous scaffolds, Nature biomedical engineering 7(1) (2023) 56-71.
[13] K.D. Mossman, G. Campi, J.T. Groves, M.L. Dustin, Altered TCR Signaling from Geometrically Repatterned Immunological Synapses, Science 310(5751) (2005) 1191-1193.
[14] R.S. O'Connor, X. Hao, K. Shen, K. Bashour, T. Akimova, W.W. Hancock, L.C. Kam, M.C. Milone, Substrate rigidity regulates human T cell activation and proliferation, J Immunol 189(3) (2012) 1330-9.
[15] H.S. Kim, T.C. Ho, M.J. Willner, M.W. Becker, H.W. Kim, K.W. Leong, Dendritic cell-mimicking scaffolds for ex vivo T cell expansion, Bioactive materials 21 (2023) 241-252.
[16] B. Chen, Y. Jia, Y. Gao, L. Sanchez, S.M. Anthony, Y. Yu, Janus particles as artificial antigen-presenting cells for T cell activation, ACS Appl Mater Interfaces 6(21) (2014) 18435-9.
[17] P. Agarwalla, E.A. Ogunnaike, S. Ahn, K.A. Froehlich, A. Jansson, F.S. Ligler, G. Dotti, Y. Brudno, Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells, Nat Biotechnol 40(8) (2022) 1250-1258.
[18] P. Vormittag, R. Gunn, S. Ghorashian, F.S. Veraitch, A guide to manufacturing CAR T cell therapies, Curr Opin Biotechnol 53 (2018) 164-181.
[19] D. Delcassian, S. Sattler, I.E. Dunlop, T cell immunoengineering with advanced biomaterials, Integrative biology : quantitative biosciences from nano to macro 9(3) (2017) 211-222.
[20] O. Chaudhuri, J. Cooper-White, P.A. Janmey, D.J. Mooney, V.B. Shenoy, Effects of extracellular matrix viscoelasticity on cellular behaviour, Nature 584(7822) (2020) 535-546.
[21] M. Saitakis, S. Dogniaux, C. Goudot, N. Bufi, S. Asnacios, M. Maurin, C. Randriamampita, A. Asnacios, C. Hivroz, Different TCR-induced T lymphocyte responses are potentiated by stiffness with variable sensitivity, Elife 6 (2017) e23190.
[22] X. Zhang, T.H. Kim, T.J. Thauland, H. Li, F.S. Majedi, C. Ly, Z. Gu, M.J. Butte, A.C. Rowat, S. Li, Unraveling the mechanobiology of immune cells, Curr Opin Biotechnol 66 (2020) 236-245.
[23] L. Gattinoni, D.E. Speiser, M. Lichterfeld, C. Bonini, T memory stem cells in health and disease, Nature Medicine 23(1) (2017) 18-27.
[24] F. Blaeschke, D. Stenger, T. Kaeuferle, S. Willier, R. Lotfi, A.D. Kaiser, M. Assenmacher, M. Doring, J. Feucht, T. Feuchtinger, Induction of a central memory and stem cell memory phenotype in functionally active CD4(+) and CD8(+) CAR T cells produced in an automated good manufacturing practice system for the treatment of CD19(+) acute lymphoblastic leukemia, Cancer Immunol Immunother 67(7) (2018) 1053-1066.
[25] L. Gattinoni, E. Lugli, Y. Ji, Z. Pos, C.M. Paulos, M.F. Quigley, J.R. Almeida, E. Gostick, Z. Yu, C. Carpenito, E. Wang, D.C. Douek, D.A. Price, C.H. June, F.M. Marincola, M. Roederer, N.P. Restifo, A human memory T cell subset with stem cell-like properties, Nat Med 17(10) (2011) 1290-7.
[26] L. Gattinoni, C.A. Klebanoff, N.P. Restifo, Paths to stemness: building the ultimate antitumour T cell, Nat Rev Cancer 12(10) (2012) 671-84.
[27] L. Xu, D. Yao, J. Tan, Z. He, Z. Yu, J. Chen, G. Luo, C. Wang, F. Zhou, X. Zha, S. Chen, Y. Li, Memory T cells skew toward terminal differentiation in the CD8+ T cell population in patients with acute myeloid leukemia, J Hematol Oncol 11(1) (2018) 93.
[28] G. Scholz, C. Jandus, L. Zhang, C. Grandclement, I.C. Lopez-Mejia, C. Soneson, M. Delorenzi, L. Fajas, W. Held, O. Dormond, P. Romero, Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells, EBioMedicine 4 (2016) 50-61.
[29] D.H. Fowler, L. Gattinoni, T memory stem cell formation: Caveat mTOR, EBioMedicine 4 (2016) 3-4.
[30] Y. Ma, T. Han, Q. Yang, J. Wang, B. Feng, Y. Jia, Z. Wei, F. Xu, Viscoelastic Cell Microenvironment: Hydrogel‐Based Strategy for Recapitulating Dynamic ECM Mechanics, Adv Funct Mater 31(24) (2021) 2100848.
[31] D.T. Wu, N. Jeffreys, M. Diba, D.J. Mooney, Viscoelastic Biomaterials for Tissue Regeneration, Tissue engineering. Part C, Methods 28.7 (2022) 289-300.
[32] N. Huebsch, Translational mechanobiology: Designing synthetic hydrogel matrices for improved in vitro models and cell-based therapies, Acta Biomater 94 (2019) 97-111.
[33] Y. Fan, Y. Li, J. Zhang, X. Ding, J. Cui, G. Wang, Z. Wang, L. Wang, Alginate Enhances Memory Properties of Antitumor CD8+ T Cells by Promoting Cellular Antioxidation, ACS Biomaterials Science & Engineering 5(9) (2019) 4717-4725.
[34] L. Da Cunha Stankevicins, M.R. Shaebani, D. Vesperini, M. Urbanska, D.A. Flormann, E. Terriac, A.K. Gad, F. Cheng, J.E. Eriksson, F. Lautenschläger, Vimentin provides target search efficiency and mechanical resilience for dendritic cell migration, bioRxiv (2020) 2020.12. 18.423401.
[35] A. Maggi, E. Ruivo, J. Fissers, C. Vangestel, S. Chatterjee, J. Joossens, F. Sobott, S. Staelens, S. Stroobants, P. Van Der Veken, L. Wyffels, K. Augustyns, Development of a novel antibody-tetrazine conjugate for bioorthogonal pretargeting, Org Biomol Chem 14(31) (2016) 7544-51.
[36] H. Cai, J. Muller, D. Depoil, V. Mayya, M.P. Sheetz, M.L. Dustin, S.J. Wind, Full control of ligand positioning reveals spatial thresholds for T cell receptor triggering, Nat Nanotechnol 13(7) (2018) 610-617.
[37] R.A. Hernandez-Lopez, W. Yu, K.A. Cabral, O.A. Creasey, M.D.P. Lopez Pazmino, Y. Tonai, A. De Guzman, A. Mäkelä, K. Saksela, Z.J. Gartner, W.A. Lim, T cell circuits that sense antigen density with an ultrasensitive threshold, Science 371(6534) (2021) 1166-1171.
[38] J. Deeg, M. Axmann, J. Matic, A. Liapis, D. Depoil, J. Afrose, S. Curado, M.L. Dustin, J.P. Spatz, T cell activation is determined by the number of presented antigens, Nano Lett 13(11) (2013) 5619-26.
[39] A.S. Cheung, D.K.Y. Zhang, S.T. Koshy, D.J. Mooney, Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells, Nat Biotechnol 36(2) (2018) 160-169.
[40] A. Durgeau, Y. Virk, S. Corgnac, F. Mami-Chouaib, Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy, Front Immunol 9 (2018) 14.
[41] S.L. Clarke, G.J. Betts, A. Plant, K.L. Wright, T.M. El-Shanawany, R. Harrop, J. Torkington, B.I. Rees, G.T. Williams, A.M. Gallimore, A.J. Godkin, CD4+CD25+FOXP3+ regulatory T cells suppress anti-tumor immune responses in patients with colorectal cancer, PLoS One 1(1) (2006) e129.
[42] B. Guo, M. Chen, Q. Han, F. Hui, H. Dai, W. Zhang, Y. Zhang, Y. Wang, H. Zhu, W. Han, CD138-directed adoptive immunotherapy of chimeric antigen receptor (CAR)-modified T cells for multiple myeloma, Journal of Cellular Immunotherapy 2(1) (2016) 28-35.
[43] Z. Wang, N. Li, K. Feng, M. Chen, Y. Zhang, Y. Liu, Q. Yang, J. Nie, N. Tang, X. Zhang, C. Cheng, L. Shen, J. He, X. Ye, W. Cao, H. Wang, W. Han, Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors, Cellular & molecular immunology 18(9) (2021) 2188-2198.
[44] B.L. Levine, J. Miskin, K. Wonnacott, C. Keir, Global Manufacturing of CAR T Cell Therapy, Mol Ther Methods Clin Dev 4 (2017) 92-101.
[45] K. Adu-Berchie, Y. Liu, D.K.Y. Zhang, B.R. Freedman, J.M. Brockman, K.H. Vining, B.A. Nerger, A. Garmilla, D.J. Mooney, Generation of functionally distinct T-cell populations by altering the viscoelasticity of their extracellular matrix, Nature biomedical engineering (2023) 1-18.
[46] A.N. Henning, R. Roychoudhuri, N.P. Restifo, Epigenetic control of CD8(+) T cell differentiation, Nat Rev Immunol 18(5) (2018) 340-356.
[47] S. Utech, R. Prodanovic, A.S. Mao, R. Ostafe, D.J. Mooney, D.A. Weitz, Microfluidic Generation of Monodisperse, Structurally Homogeneous Alginate Microgels for Cell Encapsulation and 3D Cell Culture, Adv Healthc Mater 4(11) (2015) 1628-33.
[48] L. Zeyang, Z. Hongyong, Z. Zhen, N. Haochen, H. Nan, X. Tao, G. Xiaohua, H. Chengzhi, Mild formation of core-shell hydrogel microcapsules for cell encapsulation, Biofabrication 13.2 (2020) 025002.
[49] D. Delcassian, D. Depoil, D. Rudnicka, M. Liu, D.M. Davis, M.L. Dustin, I.E. Dunlop, Nanoscale ligand spacing influences receptor triggering in T cells and NK cells, Nano Lett 13(11) (2013) 5608-14.
[50] S.C. Grindy, R. Learsch, D. Mozhdehi, J. Cheng, D.G. Barrett, Z. Guan, P.B. Messersmith, N. Holten-Andersen, Control of hierarchical polymer mechanics with bioinspired metal-coordination dynamics, Nat Mater 14(12) (2015) 1210-6.
[51] Y.R. Li, Y. Zhou, Y.J. Kim, Y. Zhu, F. Ma, J. Yu, Y.C. Wang, X. Chen, Z. Li, S. Zeng, X. Wang, D. Lee, J. Ku, T. Tsao, C. Hardoy, J. Huang, D. Cheng, A. Montel-Hagen, C.S. Seet, G.M. Crooks, S.M. Larson, J.P. Sasine, X. Wang, M. Pellegrini, A. Ribas, D.B. Kohn, O. Witte, P. Wang, L. Yang, Development of allogeneic HSC-engineered iNKT cells for off-the-shelf cancer immunotherapy, Cell Rep Med 2(11) (2021) 100449.
[52] Y. Zhu, D.J. Smith, Y. Zhou, Y.R. Li, J. Yu, D. Lee, Y.C. Wang, S. Di Biase, X. Wang, C. Hardoy, J. Ku, T. Tsao, L.J. Lin, A.T. Pham, H. Moon, J. McLaughlin, D. Cheng, R.P. Hollis, B. Campo-Fernandez, F. Urbinati, L. Wei, L. Pang, V. Rezek, B. Berent-Maoz, M.H. Macabali, D. Gjertson, X. Wang, Z. Galic, S.G. Kitchen, D.S. An, S. Hu-Lieskovan, P.J. Kaplan-Lefko, S.N. De Oliveira, C.S. Seet, S.M. Larson, S.J. Forman, J.R. Heath, J.A. Zack, G.M. Crooks, C.G. Radu, A. Ribas, D.B. Kohn, O.N. Witte, L. Yang, Development of Hematopoietic Stem Cell-Engineered Invariant Natural Killer T Cell Therapy for Cancer, Cell Stem Cell 25(4) (2019) 542-557 e9.